Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides

被引：29
|
作者：
Higashi, Yukihito [1 ,2 ]
机构：
[1] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Regenerat Med, Hiroshima 7438551, Japan
[2] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima 7348553, Japan
来源：
CELLS | 2023年 / 12卷 / 09期
关键词：
endothelial function; dyslipidemia; low-density lipoprotein cholesterol; high-density lipoprotein cholesterol; triglycerides; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; FOAM CELL-FORMATION; NITRIC-OXIDE; DEPENDENT VASODILATION; OXIDATIVE STRESS; RISK-FACTORS; MATERNAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; SERUM TRIGLYCERIDES;
D O I：
10.3390/cells12091293
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Dyslipidemia is associated with endothelial dysfunction. Endothelial dysfunction is the initial step for atherosclerosis, resulting in cardiovascular complications. It is clinically important to break the process of endothelial dysfunction to cardiovascular complications in patients with dyslipidemia. Lipid-lowering therapy enables the improvement of endothelial function in patients with dyslipidemia. It is likely that the relationships of components of a lipid profile such as low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides with endothelial function are not simple. In this review, we focus on the roles of components of a lipid profile in endothelial function.
引用
收藏
页数：15
相关论文
共 50 条
  • [11] CordyMax reduces serum oxidized LDL-cholesterol and increases HDL-cholesterol in humans with reduced HDL-cholesterol
    Zhu, JS
    Pei, Y
    Xu, ZB
    Wang, BE
    Rippe, J
    CIRCULATION, 2003, 108 (17) : 781 - 781
  • [12] LDL-cholesterol and HDL-cholesterol concentrations decrease during the day
    Miida, T
    Nakamura, Y
    Mezaki, T
    Hanyu, O
    Maruyama, S
    Horikawa, Y
    Izawa, S
    Yamada, Y
    Matsui, H
    Okada, M
    ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 241 - 249
  • [13] Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention
    Parhofer, KG
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (08) : 414 - 417
  • [14] Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects
    Natali, Andrea
    Baldi, Simona
    Bonnet, Fabrice
    Petrie, John
    Trifiro, Silvia
    Trico, Domenico
    Mari, Andrea
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 69 : 33 - 42
  • [15] The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis
    Momiyama, Yukihiko
    Ohmori, Reiko
    Fayad, Zahi A.
    Tanaka, Nobukiyo
    Kato, Ryuichi
    Taniguchi, Hiroaki
    Nagata, Masayoshi
    Ohsuzu, Fumitaka
    ATHEROSCLEROSIS, 2012, 222 (02) : 577 - 580
  • [16] CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese
    Kinoshita, M
    Teramoto, T
    Shimazu, N
    Kaneko, K
    Ohta, M
    Koike, T
    Hosogaya, S
    Ozaki, Y
    Kume, S
    Yamanaka, M
    ATHEROSCLEROSIS, 1996, 120 (1-2) : 75 - 82
  • [17] Genetic risk for low HDL-cholesterol or high LDL-cholesterol concentrations
    Oguri, Mitsutoshi
    Kato, Kimihiko
    Yoshida, Tetsuro
    Hibino, Takeshi
    Yajima, Kazuhiro
    Fujimaki, Tetsuo
    Yokoi, Kiyoshi
    Matsuo, Hitoshi
    Warita, Shunichiro
    Segawa, Tomonori
    Watanabe, Sachiro
    Metoki, Norifumi
    Yoshida, Hidemi
    Satoh, Kei
    Aoyagi, Yukitoshi
    Yasunaga, Akitomo
    Park, Hyuntae
    Tanaka, Masashi
    Nozawa, Yoshinori
    Ichihara, Sahoko
    Yamada, Yoshiji
    CIRCULATION, 2007, 116 (16) : 507 - 508
  • [18] Reference ranges for serum total cholesterol, HDL-cholesterol, LDL-cholesterol, and VLDL-cholesterol and triglycerides in healthy iranian ahvaz population
    Jalali M.T.
    Honomaror A.M.
    Rekabi A.
    Latifi M.
    Indian Journal of Clinical Biochemistry, 2013, 28 (3) : 277 - 282
  • [19] POSSIBILITIES FOR THE INFLUENCE ON HDL-CHOLESTEROL, TOTAL-CHOLESTEROL, LDL-CHOLESTEROL, TRIGLYCERIDES AND ATHEROGENETIC INDEXES BY STANDARDIZED CURE-PRESCRIPTIONS
    KOZARISZCZUK, G
    HUNGER, KL
    WORMS, F
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1982, 37 (38): : 1647 - 1652
  • [20] INFLUENCE OF BEZAFIBRATE AND COLESTIPOL ON LDL-CHOLESTEROL, LDL-APOLIPOPROTEIN-B AND HDL-CHOLESTEROL IN HYPERLIPOPROTEINEMIA
    KLOSIEWICZLATOSZEK, L
    NOWICKA, G
    SZOSTAK, WB
    NARUSZEWICZ, M
    ATHEROSCLEROSIS, 1987, 63 (2-3) : 203 - 209
12345